| Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease (NCT01886599) | Bristol-Myers Squibb | 2012-11-01 |
| Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer (NCT01720836) | Olivera Finn | 2012-11-01 |
| Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Subacute SCI (NCT01739023) | W. Dalton Dietrich | 2012-11-01 |
| Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel (NCT01687205) | CONRAD | 2012-11-01 |
| S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma (NCT01668719) | SWOG Cancer Research Network | 2012-11-01 |
| A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors (NCT01733004) | Merrimack Pharmaceuticals | 2012-11-01 |
| Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits (NCT01734759) | Mayo Clinic | 2012-11-01 |
| A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer (NCT01808040) | University of Wisconsin, Madison | 2012-11-01 |
| Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM (NCT01708044) | AstraZeneca | 2012-11-01 |
| Nutrient Sensing in the Duodenum (NCT01694004) | Vanderbilt University Medical Center | 2012-11-01 |
| Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers (NCT01723891) | Hyundai Pharmaceutical Co., LTD. | 2012-11-01 |
| Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults (NCT01737892) | Amphastar Pharmaceuticals, Inc. | 2012-11-01 |
| Impact of Three Body Positioning Strategies in the Drainage Fluids After Coronary Artery Bypass Surgery (NCT02525289) | University of Sao Paulo General Hospital | 2012-11-01 |
| A Comparison of the Bioavailability of OZ439 When Delivered Directly to the Small Intestine, or Via the Oral Route (NCT01732588) | Medicines for Malaria Venture | 2012-11-01 |
| South Asian Women & Yoga Education Study (NCT01667835) | Kwantlen Polytechnic University | 2012-11-01 |
| Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure (NCT01724398) | Third Affiliated Hospital, Sun Yat-Sen University | 2012-11-01 |
| Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel® (NCT01725620) | LG Life Sciences | 2012-11-01 |
| A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State (NCT01706796) | Pfizer | 2012-11-01 |
| Effects of Pregabalin on Post-cesarean Pain (NCT01719705) | Mansoura University | 2012-11-01 |
| A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia (NCT01651273) | Bristol-Myers Squibb | 2012-11-01 |
| First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy Volunteers (NCT01808469) | Light Chain Bioscience - Novimmune SA | 2012-11-01 |
| Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease (NCT01925352) | The First Affiliated Hospital with Nanjing Medical University | 2012-11-01 |
| Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers (NCT01717027) | Pain Therapeutics | 2012-11-01 |
| Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib (NCT01725230) | AstraZeneca | 2012-11-01 |
| Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment (NCT01763190) | Bristol-Myers Squibb | 2012-11-01 |
| Clinical Investigation of Expanded Designs of a Multifocal IOL (NCT01714635) | Abbott Medical Optics | 2012-11-01 |
| 2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy Subjects (NCT01733875) | Celgene | 2012-11-01 |
| A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma (NCT01703312) | Novartis Pharmaceuticals | 2012-11-01 |
| A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects (NCT01911741) | Astellas Pharma Europe B.V. | 2012-11-01 |
| Impulsivity and Stimulant Administration (NCT01978431) | Yale University | 2012-11-01 |
| Safety, Tolerability and Pharmacokinetics of Different Multiple Doses of BI 207127 BID and Multiple Doses of BI 207127 Combined With Faldaprevir in Healthy Male and Female Subjects (NCT01737996) | Boehringer Ingelheim | 2012-11-01 |
| Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ (NCT01791374) | Amgen | 2012-11-01 |
| A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression (NCT01774045) | BioLite, Inc. | 2012-11-01 |
| Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris (NCT01769235) | Sun Pharmaceutical Industries, Inc. | 2012-11-01 |
| TD-1211 IV/Oral Mass Balance Study (NCT01702194) | Glycyx Therapeutics | 2012-11-01 |
| Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects (NCT01723735) | Sanofi | 2012-11-01 |
| YH4808 Postprandial PK/PD Study in Healthy Subjects (NCT01761513) | Yuhan Corporation | 2012-11-01 |
| Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Cardiotrophin-1 in Healthy Volunteers (NCT01334697) | Digna Biotech S.L. | 2012-11-01 |
| Evaluate the Safety and Exploratory Efficacy of GC1119 (NCT01653444) | Green Cross Corporation | 2012-11-01 |
| Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC) (NCT01721525) | Memorial Sloan Kettering Cancer Center | 2012-11-01 |
| Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme (NCT01648348) | National Cancer Institute (NCI) | 2012-11-01 |
| Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients (NCT01902251) | Astellas Pharma Europe B.V. | 2012-11-01 |
| A Study of Vanucizumab (RO5520985) Alone or in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors (NCT01688206) | Hoffmann-La Roche | 2012-10-31 |
| An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (NCT01703988) | Biogen | 2012-10-31 |
| A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers (NCT01702493) | Sirtris, a GSK Company | 2012-10-30 |
| An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer (NCT01658878) | Bristol-Myers Squibb | 2012-10-30 |
| Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048) (NCT01678131) | Merck Sharp & Dohme LLC | 2012-10-30 |
| Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function (NCT01716455) | Shire | 2012-10-29 |
| Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant (NCT01588015) | City of Hope Medical Center | 2012-10-29 |
| CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies (NCT01664910) | M.D. Anderson Cancer Center | 2012-10-29 |
| Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma (NCT01590732) | M.D. Anderson Cancer Center | 2012-10-29 |
| A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment (NCT01711723) | GlaxoSmithKline | 2012-10-29 |
| Ruxolitinib for Adult T-Cell Leukemia (NCT01712659) | National Cancer Institute (NCI) | 2012-10-26 |
| A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) (NCT01455701) | Hoffmann-La Roche | 2012-10-26 |
| Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers (NCT01685671) | Chong Kun Dang Pharmaceutical | 2012-10-26 |
| Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors (NCT01661400) | Washington University School of Medicine | 2012-10-26 |
| Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma (NCT01701986) | M.D. Anderson Cancer Center | 2012-10-25 |
| Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization (NCT01744054) | Washington University School of Medicine | 2012-10-25 |
| Interactions Between Intravenous Cocaine and Acetazolamide or Quinine (NCT01851473) | National Institute on Drug Abuse (NIDA) | 2012-10-24 |
| Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet (NCT05436769) | University of Karachi | 2012-10-23 |
| Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer (NCT01711541) | National Cancer Institute (NCI) | 2012-10-22 |
| Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History (NCT01758731) | University of Colorado, Denver | 2012-10-22 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers (NCT01702467) | GlaxoSmithKline | 2012-10-19 |
| A Phase I Study of Oral BGJ398 in Asian Patients (NCT01697605) | Novartis Pharmaceuticals | 2012-10-19 |
| Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery (NCT01823562) | Ohio State University Comprehensive Cancer Center | 2012-10-17 |
| This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects (NCT01706315) | GlaxoSmithKline | 2012-10-17 |
| Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease (NCT01552434) | M.D. Anderson Cancer Center | 2012-10-16 |
| Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer (NCT01671774) | Astellas Pharma Global Development, Inc. | 2012-10-16 |
| Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP) (NCT01711684) | Rockefeller University | 2012-10-16 |
| MSCs For Treatment of Azoospermic Patients (NCT02025270) | Al-Azhar University | 2012-10-15 |
| Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors (NCT01653470) | Bristol-Myers Squibb | 2012-10-12 |
| Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers (NCT01684605) | Chong Kun Dang Pharmaceutical | 2012-10-12 |
| A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency (NCT01706783) | Novo Nordisk A/S | 2012-10-12 |
| A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease (NCT01559363) | Kadmon, a Sanofi Company | 2012-10-11 |
| A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis (NCT01636557) | Janssen Research & Development, LLC | 2012-10-11 |
| Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma (NCT01794520) | AbbVie | 2012-10-10 |
| Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects (NCT01691872) | GlaxoSmithKline | 2012-10-10 |
| Phase I/II Study of DFP-10917 in Patients With Acute Leukemia (NCT01702155) | Delta-Fly Pharma, Inc. | 2012-10-10 |
| A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors (NCT01714739) | Bristol-Myers Squibb | 2012-10-07 |
| Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease (NCT01677572) | Biogen | 2012-10-05 |
| Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (NCT01712646) | National Institute of Mental Health (NIMH) | 2012-10-05 |
| High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer (NCT01655836) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-10-04 |
| This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers. (NCT01702376) | GlaxoSmithKline | 2012-10-03 |
| Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients (NCT01625286) | AstraZeneca | 2012-10-03 |
| Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma (NCT01582776) | The Lymphoma Academic Research Organisation | 2012-10-03 |
| Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas (NCT01434602) | National Cancer Institute (NCI) | 2012-10-02 |
| Cognitive Activation Therapy for MCI: A Randomized Control Study (NCT01641328) | Rotman Research Institute at Baycrest | 2012-10-01 |
| Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma (NCT01460901) | Children's Mercy Hospital Kansas City | 2012-10-01 |
| Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer (NCT01711515) | National Cancer Institute (NCI) | 2012-10-01 |
| Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients (NCT01433133) | Medgenics Medical Israel Ltd. | 2012-10-01 |
| Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease. (NCT01711853) | Boehringer Ingelheim | 2012-10-01 |
| Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET (NCT01699828) | Centre for Addiction and Mental Health | 2012-10-01 |
| Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients (NCT01678898) | Protalix | 2012-10-01 |
| A Multi-Center, Open-Label Study (NCT01468259) | Chelsea Therapeutics | 2012-10-01 |
| Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males (NCT01725009) | UCB Japan Co. Ltd. | 2012-10-01 |
| A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies (NCT01703572) | OncoMed Pharmaceuticals, Inc. | 2012-10-01 |
| Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease (NCT01711073) | Proteonomix, Inc. | 2012-10-01 |
| Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers (NCT01690286) | Janssen Research & Development, LLC | 2012-10-01 |
| Expanded Natural Killer (NK) Cells for Multiple Myeloma Study (NCT01040026) | University Hospital, Basel, Switzerland | 2012-10-01 |
| Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects (NCT02291510) | Elcelyx Therapeutics, Inc. | 2012-10-01 |